798 related articles for article (PubMed ID: 12399438)
1. Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy.
Bagnasco M; Dube MG; Kalra PS; Kalra SP
Endocrinology; 2002 Nov; 143(11):4409-21. PubMed ID: 12399438
[TBL] [Abstract][Full Text] [Related]
2. Increased leptin expression in the dorsal vagal complex suppresses adiposity without affecting energy intake and metabolic hormones.
Boghossian S; Lecklin A; Dube MG; Kalra PS; Kalra SP
Obesity (Silver Spring); 2006 Jun; 14(6):1003-9. PubMed ID: 16861605
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus.
Dhillon H; Kalra SP; Kalra PS
Mol Ther; 2001 Aug; 4(2):139-45. PubMed ID: 11482985
[TBL] [Abstract][Full Text] [Related]
4. Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin.
Bagnasco M; Dube MG; Katz A; Kalra PS; Kalra SP
Obes Res; 2003 Dec; 11(12):1463-70. PubMed ID: 14694210
[TBL] [Abstract][Full Text] [Related]
5. Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels.
Dube MG; Beretta E; Dhillon H; Ueno N; Kalra PS; Kalra SP
Diabetes; 2002 Jun; 51(6):1729-36. PubMed ID: 12031959
[TBL] [Abstract][Full Text] [Related]
6. Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: effects on serum ghrelin and appetite-regulating genes.
Beretta E; Dube MG; Kalra PS; Kalra SP
Pediatr Res; 2002 Aug; 52(2):189-98. PubMed ID: 12149495
[TBL] [Abstract][Full Text] [Related]
7. Hypothyroidism Induces Hypophagia Associated with Alterations in Protein Expression of Neuropeptide Y and Proopiomelanocortin in the Arcuate Nucleus, Independently of Hypothalamic Nuclei-Specific Changes in Leptin Signaling.
Calvino C; Império GE; Wilieman M; Costa-E-Sousa RH; Souza LL; Trevenzoli IH; Pazos-Moura CC
Thyroid; 2016 Jan; 26(1):134-43. PubMed ID: 26538454
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
Crowley WR; Ramoz G; Keefe KA; Torto R; Kalra SP; Hanson GR
Neuroscience; 2005; 132(1):167-73. PubMed ID: 15780475
[TBL] [Abstract][Full Text] [Related]
9. Leptin regulates appetite-related neuropeptides in the hypothalamus of developing rats without affecting food intake.
Proulx K; Richard D; Walker CD
Endocrinology; 2002 Dec; 143(12):4683-92. PubMed ID: 12446596
[TBL] [Abstract][Full Text] [Related]
10. Normal distribution of body weight gain in male Sprague-Dawley rats fed a high-energy diet.
Archer ZA; Rayner DV; Rozman J; Klingenspor M; Mercer JG
Obes Res; 2003 Nov; 11(11):1376-83. PubMed ID: 14627759
[TBL] [Abstract][Full Text] [Related]
11. Introduction of a high-energy diet acutely up-regulates hypothalamic cocaine and amphetamine-regulated transcript, Mc4R and brown adipose tissue uncoupling protein-1 gene expression in male Sprague-Dawley rats.
Archer ZA; Rayner DV; Duncan JS; Bell LM; Mercer JG
J Neuroendocrinol; 2005 Jan; 17(1):10-7. PubMed ID: 15720470
[TBL] [Abstract][Full Text] [Related]
12. Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study.
Dhillon H; Kalra SP; Prima V; Zolotukhin S; Scarpace PJ; Moldawer LL; Muzyczka N; Kalra PS
Regul Pept; 2001 Jun; 99(2-3):69-77. PubMed ID: 11384767
[TBL] [Abstract][Full Text] [Related]
13. Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats.
Li G; Mobbs CV; Scarpace PJ
Diabetes; 2003 Aug; 52(8):1951-7. PubMed ID: 12882910
[TBL] [Abstract][Full Text] [Related]
14. Leptin secretion and hypothalamic neuropeptide and receptor gene expression in sheep.
Sorensen A; Adam CL; Findlay PA; Marie M; Thomas L; Travers MT; Vernon RG
Am J Physiol Regul Integr Comp Physiol; 2002 Apr; 282(4):R1227-35. PubMed ID: 11893629
[TBL] [Abstract][Full Text] [Related]
15. Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress.
Makino S; Asaba K; Nishiyama M; Hashimoto K
Neuroendocrinology; 1999 Sep; 70(3):160-7. PubMed ID: 10516478
[TBL] [Abstract][Full Text] [Related]
16. Circulating hormones and hypothalamic energy balance: regulatory gene expression in the Lou/C and Wistar rats.
Mitchell SE; Nogueiras R; Rance K; Rayner DV; Wood S; Dieguez C; Williams LM
J Endocrinol; 2006 Sep; 190(3):571-9. PubMed ID: 17003258
[TBL] [Abstract][Full Text] [Related]
17. NPY-induced overfeeding suppresses hypothalamic NPY mRNA expression: potential roles of plasma insulin and leptin.
McMinn JE; Seeley RJ; Wilkinson CW; Havel PJ; Woods SC; Schwartz MW
Regul Pept; 1998 Sep; 75-76():425-31. PubMed ID: 9802439
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats.
Li G; Zhang Y; Wilsey JT; Scarpace PJ
Diabetologia; 2005 Nov; 48(11):2376-85. PubMed ID: 16205885
[TBL] [Abstract][Full Text] [Related]
19. Leptin sensitivity in the developing rat hypothalamus.
Carlo AS; Pyrski M; Loudes C; Faivre-Baumann A; Epelbaum J; Williams LM; Meyerhof W
Endocrinology; 2007 Dec; 148(12):6073-82. PubMed ID: 17872366
[TBL] [Abstract][Full Text] [Related]
20. Severe leptin resistance in brown fat-deficient uncoupling protein promoter-driven diphtheria toxin A mice despite suppression of hypothalamic neuropeptide Y and circulating corticosterone concentrations.
Mantzoros CS; Frederich RC; Qu D; Lowell BB; Maratos-Flier E; Flier JS
Diabetes; 1998 Feb; 47(2):230-8. PubMed ID: 9519718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
